STERIS plc (NYSE: STE ) reported first-quarter fiscal 2025 adjusted earnings per share of $2.03, up 10.3% from the year-ago quarter''s figure. The figure surpassed the Zacks Consensus Estimate by 2 cents. The adjustment excludes the impacts of certain non-recurring charges, such as the amortization of acquired intangible assets and acquisition and integration-related charges, among others. The company''s GAAP EPS was $1.41, up 7.6% from the year-ago level of $1.31. Revenues in Detail Revenues of $1.28 billion from continuing operations increased 8.5% year over year. The figure outpaced the Zacks Consensus Estimate by 1.5%. Organic revenues at the constant exchange rate or CER rose 6% year over year. Quarter in Detail The company operates through three segments — Healthcare, Applied Sterilization Technologies ("AST"), and Life Sciences. Revenues at Healthcare rose 10% year over year to $901.2 million (up 5% on a CER organic basis). While there was a 23% improvement in consumable revenues and a 14% increase in service revenues, these were partially offset by a 10% decline in capital equipment revenues.

STERIS plc (NYSE:NYSE:STE) Q1 2025 Earnings Conference Call August 7, 2024 9:00 AM ETCompany ParticipantsJulie Winter - Investor RelationsMike Tokich -…

No summary available.

WASHINGTON (dpa-AFX) - STERIS plc (STE) released earnings for its first quarter that increased from the same period last year and beat the Street estimates.The company''s earnings came in at $145.4…

STERIS reports strong Q1 FY2025: Revenue up 8% to $1.3B, adjusted EPS rises to $2.03. Healthcare segment shines with 10% growth. Company reaffirms optimistic full-year outlook despite challenges in Life Sciences.

DUBLIN, IRELAND , Aug. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total revenue from continuing operations for the first quarter of fiscal 2025 increased 8% to $1.3 billion compared with $1.2 billion in the first quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the first quarter increased 6%.

https://www.investing.com/news/company-news/steris-plc-shareholders-approve-board-and-auditor-proposals-93CH-3550517

BURLINGAME, CALIFORNIA, UNITED STATES, July 25, 2024 /⁨EINPresswire.com⁩/ -- Coherent Market Insights Published the Latest Bio Decontamination Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, …

DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 first quarter financial results at 9:00 a.m. ET on August 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.

STERIS plc (NYSE: STE ) is expected to release first-quarter fiscal 2025 results on Aug 6. Earnings Surprise History STE has a strong earnings surprise history. It beat on earnings in three of the trailing four quarters and missed the same once, the average surprise being 2.21%. In the last reported quarter, the company posted adjusted earnings per share of $2.41, in line with the Zacks Consensus Estimate. Q1 Estimates The Zacks Consensus Estimate for STERIS'' first-quarter fiscal 2025 revenues is pegged at $1.26 billion. This suggests a decrease of 1.7% from the year-ago reported figure. The Zacks Consensus Estimate for EPS of $2.03 indicates a year-over-year rise of 1.5%. Estimate Revision Trend Ahead of Earnings Estimates for STERIS'' fiscal first-quarter earnings have remained constant at $2.03 per share in the past 30 days. Let''s take a look at how things might have shaped up for the MedTech major before the announcement. Factors at Play Healthcare In the fiscal fourth quarter, growth across capital equipment, consumables, and services was robust, favored by positive price and high productivity.